Getty Images landmark AI trial; Labubu counterfeit phenomenon; StockX trends; and much more

European pharma “faces an existential threat”, warns Sanofi’s IP head at the EUIPO’s IP Enforcement Summit. Plus… Revamped trademark legislation to …